Excess mortality after HIV seroconversion has greatly decreased in the past 10 years
Dr K Porter, MRC Clinical Trials Unit, London, UK; email@example.com
What is the risk of death in HIV-infected people compared with the general population? Has this risk changed since the introduction of highly active antiretroviral therapy (HAART)?
inception cohort followed up for a median 6.3 years.
10 European countries, Australia, and Canada.
16 534 patients ⩾15 years of age at HIV seroconversion (median age 29 y, 78% men) who had well-estimated dates of seroconversion (within 18 mo) and exposure to HIV through injection drug use (18% of patients), sex between men (57%), or heterosexual sex (24%).
calendar period of follow-up (before 1996, 1996–7, 1998–9, 2000–1, 2002–3, and 2004–6), sex, age at seroconversion, and HIV exposure category.
mortality, excess …